Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
(17 sites) United States
Children's Hospital of Alabama, Birmingham, Alabama Children's Hospital Los Angeles, Los Angeles, California Children's Hospital of Orange County, Orange, California Children's Hospital Colorado, Aurora, Colorado Children's National Medical Center, Washington D.C., District of Columbia Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia Lurie Children's Hospital-Chicago, Chicago, Illinois Riley Hospital for Children, Indianapolis, Indiana C S Mott Children's Hospital, Ann Arbor, Michigan University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota Washington University School of Medicine, St Louis, Missouri Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania Saint Jude Children's Research Hospital, Memphis, Tennessee Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas UMC Cancer Center / UMC Health System, Lubbock, Texas Seattle Children's Hospital, Seattle, Washington